Background Coverage levels for many recommended adult vaccinations are low. The cost-
effectiveness research literature on adult vaccinations has not been synthesized in recent …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

BACKGROUND AND OBJECTIVES Current routine immunizations for children aged≤ 10
years in the United States in 2019 cover 14 vaccine-preventable diseases. We characterize …

The reemergence of pertussis in the last two decades led to the introduction of adolescents
and adults immunization strategies of tetanus–diphtheria–acellular pertussis vaccines …

METHODS An economic model followed the 2017 US birth cohort from birth through death;
impact was modeled via a decision tree for each of the vaccines recommended for children …

Objective This exploratory study estimates the economic value of the current vaccination
program and increased coverage against four preventable diseases in older adults in the …

Despite vaccination recommendations, the burden of vaccine-preventable diseases remains
high in older adults in the United States (US), contributing to substantial morbidity, mortality …

Chronic obstructive pulmonary disease (COPD) may increase the risk and severity of
pertussis infection. Health care resource utilization (HCRU) and direct medical costs (DMC) …

Background Primary care visits can serve many purposes and potentially influence health
behaviors. Although previous studies suggest that increasing primary care provider numbers …